{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:15:18Z","timestamp":1792016118469,"version":"4.4.0"},"reference-count":99,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2008,10,10]]},"abstract":"<jats:p> Despite the impact of combination antiretroviral therapy (cART) on HIV-related mortality, malignancy remains an important cause of death in the current era. Although the advent of cART has resulted in reductions in the incidence of Kaposi's sarcoma and non-Hodgkin's lymphoma, non\u2013AIDS-defining malignancies present an increased risk for HIV-infected patients, characterized by some common clinical features, generally with a more aggressive behavior and a more advanced disease at diagnosis, which is responsible for poorer patient outcomes. Specific therapeutic recommendations are lacking for these new nonopportunistic malignancies, such as Hodgkin's lymphoma, anal cancer, lung cancer, hepatocarcinoma, and many others. Antiretroviral agents have a propensity for causing drug interactions as a result of their ability to either inhibit or induce the cytochrome P450 (CYP) enzyme system. Because many antineoplastic drugs are also metabolized by the CYP system, coadministration with cART could result in either drug accumulation with increased toxicity, or decreased efficacy of one or both classes of drugs. Further research delineating the combined safety and pharmacokinetics of antiretrovirals and antineoplastic therapy is necessary. Special considerations of these AIDS-related and non\u2013AIDS-related malignancies and their clinical and therapeutic aspects constitute the subject of this review. <\/jats:p>","DOI":"10.1200\/jco.2008.16.8252","type":"journal-article","created":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T01:10:01Z","timestamp":1214874601000},"page":"4834-4842","source":"Crossref","is-referenced-by-count":98,"title":["AIDS-Related Malignancies: State of the Art and Therapeutic Challenges"],"prefix":"10.1200","volume":"26","author":[{"given":"Jean-Philippe","family":"Spano","sequence":"first","affiliation":[{"name":"From the Service d'Oncologie M\u00e9dicale and Service de Maladies Infectieuses et Tropicales, Assistance Publique H\u00f4pitaux de Paris, Groupe hospitalier Piti\u00e9-Salp\u00eatri\u00e8re; Universit\u00e9 Pierre et Marie Curie, Universit\u00e9 Paris; L'Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Unit\u00e9 Mixte de Recherche Scientifique S 720; H\u00f4pital Saint Louis, D\u00e9partement d'Immunologie Clinique, Paris; and Groupe Hospitalier de Nice, H\u00f4pital de l'Archet, Service d'H\u00e9matologie, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Costagliola","sequence":"additional","affiliation":[{"name":"From the Service d'Oncologie M\u00e9dicale and Service de Maladies Infectieuses et Tropicales, Assistance Publique H\u00f4pitaux de Paris, Groupe hospitalier Piti\u00e9-Salp\u00eatri\u00e8re; Universit\u00e9 Pierre et Marie Curie, Universit\u00e9 Paris; L'Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Unit\u00e9 Mixte de Recherche Scientifique S 720; H\u00f4pital Saint Louis, D\u00e9partement d'Immunologie Clinique, Paris; and Groupe Hospitalier de Nice, H\u00f4pital de l'Archet, Service d'H\u00e9matologie, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Katlama","sequence":"additional","affiliation":[{"name":"From the Service d'Oncologie M\u00e9dicale and Service de Maladies Infectieuses et Tropicales, Assistance Publique H\u00f4pitaux de Paris, Groupe hospitalier Piti\u00e9-Salp\u00eatri\u00e8re; Universit\u00e9 Pierre et Marie Curie, Universit\u00e9 Paris; L'Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Unit\u00e9 Mixte de Recherche Scientifique S 720; H\u00f4pital Saint Louis, D\u00e9partement d'Immunologie Clinique, Paris; and Groupe Hospitalier de Nice, H\u00f4pital de l'Archet, Service d'H\u00e9matologie, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Mounier","sequence":"additional","affiliation":[{"name":"From the Service d'Oncologie M\u00e9dicale and Service de Maladies Infectieuses et Tropicales, Assistance Publique H\u00f4pitaux de Paris, Groupe hospitalier Piti\u00e9-Salp\u00eatri\u00e8re; Universit\u00e9 Pierre et Marie Curie, Universit\u00e9 Paris; L'Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Unit\u00e9 Mixte de Recherche Scientifique S 720; H\u00f4pital Saint Louis, D\u00e9partement d'Immunologie Clinique, Paris; and Groupe Hospitalier de Nice, H\u00f4pital de l'Archet, Service d'H\u00e9matologie, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Oksenhendler","sequence":"additional","affiliation":[{"name":"From the Service d'Oncologie M\u00e9dicale and Service de Maladies Infectieuses et Tropicales, Assistance Publique H\u00f4pitaux de Paris, Groupe hospitalier Piti\u00e9-Salp\u00eatri\u00e8re; Universit\u00e9 Pierre et Marie Curie, Universit\u00e9 Paris; L'Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Unit\u00e9 Mixte de Recherche Scientifique S 720; H\u00f4pital Saint Louis, D\u00e9partement d'Immunologie Clinique, Paris; and Groupe Hospitalier de Nice, H\u00f4pital de l'Archet, Service d'H\u00e9matologie, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Khayat","sequence":"additional","affiliation":[{"name":"From the Service d'Oncologie M\u00e9dicale and Service de Maladies Infectieuses et Tropicales, Assistance Publique H\u00f4pitaux de Paris, Groupe hospitalier Piti\u00e9-Salp\u00eatri\u00e8re; Universit\u00e9 Pierre et Marie Curie, Universit\u00e9 Paris; L'Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Unit\u00e9 Mixte de Recherche Scientifique S 720; H\u00f4pital Saint Louis, D\u00e9partement d'Immunologie Clinique, Paris; and Groupe Hospitalier de Nice, H\u00f4pital de l'Archet, Service d'H\u00e9matologie, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Ancelle-Park R: Expanded European AIDS case definition. Lancet 341:441,1993,","DOI":"10.1016\/0140-6736(93)93040-8"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.01.096"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61050-2"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/84.20.1593"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a117008"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970301)79:5<1004::AID-CNCR17>3.0.CO;2-5"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)09028-4"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.610"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199905070-00014"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009567"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji072"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000238411.75324.59"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1086\/375844"},{"key":"R14","unstructured":"Lewden C, May T, Rosenthal E, et al: Causes of death among HIV-infected adults in France in 2005 and evolution since 2000. Bull Epidemiol Hebdomadaire 48:379,2006-382,"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000164033.02947.e3"},{"key":"R16","unstructured":"Spano JP, Khayat D: Special considerations in the management of human immunodeficiency virus-associated malignancies. Am Soc Clin Oncol Ed Book 472,2007-476,"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.4072"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1126\/science.7997879"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200312000-00007"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68649-2"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc070508"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.10-6-412"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2007.12.025"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.9.1201"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.10.162"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70036-0"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.7.2445"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.2.683"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.8.2353"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.6.1876"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.3.1112"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1097\/01.coc.0000045921.91037.C8"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20780"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06452.x"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-8428(01)00165-2"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1016\/S0755-4982(04)98968-3"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.8.2339"},{"key":"R38","unstructured":"INSERM U720: \u00c9pid\u00e9miologie Clinique et Traitement de l'Infection \u00e0 VIH: Retour d'Informations Clinico-Epid\u00e9miologiques.  Septembre 2007, http:\/\/www.ccde.fr"},{"key":"R39","unstructured":"Raphael M, Borish B, Jaffe ES: Lymphomas associated with infection by the human immunodeficiency virus, in Jaffe ES, Harris NL, Stein H (eds): World Health Organization Classification of Tumours: Pathology and Genetics Tumours of Haematopoietic and Lymphoid Tissues.  Lyon, France, IARC Press, 2001"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000138177.10829.5c"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06464.x"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.12.3406"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200307040-00013"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010101)91:1<155::AID-CNCR20>3.0.CO;2-B"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3589"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.4684"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1437"},{"key":"R48","unstructured":"Wyen C, Faetkenheuer G, Oette M, et al: Treatment of AIDS-related lymphoma: Rituximab may be beneficial even in severely immunosupressed patients.  15th Conference on Retroviruses and Opportunistic Infections. Boston, MA, 3-6 February, 2008 (abstr 1026)"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200211283472215"},{"key":"R50","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-08-3300"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06943.x"},{"key":"R52","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200301030-00011"},{"key":"R53","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-051771"},{"key":"R54","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200111090-00007"},{"key":"R55","unstructured":"Heard I, Foulot H, Potard V, Costagliola D, Chapron C: Cervical cancer in HIV-positive women.  23rd International Papillomavirus Conference, September 1-7, 2006, Prague, Czech Republic"},{"key":"R56","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.3.226"},{"key":"R57","doi-asserted-by":"crossref","unstructured":"Heard I, Palefsky JM, Karatchkine MD: The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antiviral Therapy 9:13,2004-22,","DOI":"10.1177\/135965350400900117"},{"key":"R58","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.4908"},{"key":"R59","unstructured":"Robinson W: Invasive and preinvasive cervical neoplasia in human immunodeficiency virus-infected women. Semin Oncol 27:463,2000-470,"},{"key":"R60","doi-asserted-by":"publisher","DOI":"10.1097\/01.cco.0000239886.13537.ed"},{"key":"R61","doi-asserted-by":"crossref","unstructured":"Bruyand M, Thiebaut R, Lawson-Ayayi S, et al: Immunodeficiency and risk of AIDs-defining and non-AIDs-defining cancers: ANRS CO3 Aquitaine Cohort, 1998 to 2006.  15th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 3-6 February, 2008 (abstr 15)","DOI":"10.1186\/1750-9378-4-S2-O3"},{"key":"R62","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-024109"},{"key":"R63","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-09-047498"},{"key":"R64","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(03)00046-7"},{"key":"R65","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00122-8"},{"key":"R66","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04934.x"},{"key":"R67","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10479"},{"key":"R68","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200008150-00009"},{"key":"R69","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg408"},{"key":"R70","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0989"},{"key":"R71","unstructured":"Piketti C, Selinger-Leneman H, Grabar S, et al: Dramatic increase in the incidence of anal cancer despite HAART in the French Hospital Database of HIV.  XVI International AIDS Conference, Toronto, Canada (abstr TUAB0305)"},{"key":"R72","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199704150-00004"},{"key":"R73","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3281c61201"},{"key":"R74","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.19.1822"},{"key":"R75","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)03409-5"},{"key":"R76","unstructured":"Roelofsen F, Bosset JF, Eschwege F, et al: Concomitant radiotherapy and chemotherapy superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomised trial of the EORTC Radiotherapy and Gastrointestinal Co-operative Groups. Proc Am Soc Clin Oncol 14:194,1995-199,  (abstr 454)"},{"key":"R77","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.2810"},{"key":"R78","doi-asserted-by":"crossref","unstructured":"Kinsella TJ, Kinsella MT, Reynolds H, et al: Comparable tumor response and acute\/late normal tissue toxicities with standard combined modality treatment for anal squamous cell carcinomas in HIV+ and HIV\u2212 patients. Int J Radiat Oncol Biol Phys 63:S16,2005,  (abstr 37)","DOI":"10.1016\/j.ijrobp.2005.07.033"},{"key":"R79","doi-asserted-by":"publisher","DOI":"10.1385\/MO:21:2:109"},{"key":"R80","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.052373"},{"key":"R81","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<563::AID-CNCR11>3.0.CO;2-D"},{"key":"R82","doi-asserted-by":"publisher","DOI":"10.1016\/0169-5002(95)00596-X"},{"key":"R83","doi-asserted-by":"publisher","DOI":"10.1378\/chest.102.6.1704"},{"key":"R84","doi-asserted-by":"publisher","DOI":"10.1378\/chest.103.2.410"},{"key":"R85","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800840808"},{"key":"R86","doi-asserted-by":"crossref","unstructured":"Duclos-Vall\u00e9e JC, Feray C, Sebagh M, et al: Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 47:407,2008-417,","DOI":"10.1002\/hep.21990"},{"key":"R87","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603282"},{"key":"R88","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544020-00001"},{"key":"R89","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.3.4.583"},{"key":"R90","doi-asserted-by":"publisher","DOI":"10.1023\/A:1013164013375"},{"key":"R91","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199902040-00019"},{"key":"R92","unstructured":"Parameswaran R, Sweeney C, Einhorn LH: Interaction between highly active antiretroviral therapy (HAART) and taxanes: A report of two cases. Proc Am Soc Clin Oncol 21:95b,2002,  (abstr 2194)"},{"key":"R93","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2007.00827.x"},{"key":"R94","doi-asserted-by":"publisher","DOI":"10.1111\/j.0902-4441.2005.t01-1-EJH2435.x"},{"key":"R95","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh464"},{"key":"R96","doi-asserted-by":"publisher","DOI":"10.1007\/s002800051025"},{"key":"R97","doi-asserted-by":"publisher","DOI":"10.1124\/mol.56.2.383"},{"key":"R98","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-1173-1_3"},{"key":"R99","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-200208010-00001"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2008.16.8252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T20:02:21Z","timestamp":1653508941000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2008.16.8252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,10]]},"references-count":99,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2008,10,10]]}},"alternative-id":["10.1200\/JCO.2008.16.8252"],"URL":"https:\/\/doi.org\/10.1200\/jco.2008.16.8252","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,10]]}}}